Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey-Reference-Cited by-同舟云学术

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Published:2019-10 Issue: Volume:136 Page:145-147
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Levy Antonin^ORCID,Hendriks Lizza E.L.,Le Péchoux Cécile,Falk Sally,Besse Benjamin,Novello Silvia,Dingemans Anne-Marie C.,Hasan Baktiar,Reck Martin,Berghmans Thierry,Faivre-Finn Corinne

Funder

NIHR Manchester Biomedical Research Centre

La Ligue contre le cancer from France

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. A meta-analysis of thoracic radiotherapy for small-cell lung cancer;Pignon;N. Engl. J. Med.,1992

2. ESMO Guidelines Working Group. Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Früh;Ann. Oncol.,2013

3. https://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf; Accessed on 04/15/2019.

4. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide;Turrisi;N. Engl. J. Med.,1999

5. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma;Sloan;J. Clin. Oncol.,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. A Phase Ii Study of Accelerated Hyperfractionated Thoracic Radiotherapy with Dose Escalation to 54 Gy Concurrently with Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Long-Term Results at a Single Institution;2024

3. Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials;Seminars in Radiation Oncology;2023-10

4. Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative;Practical Radiation Oncology;2023-09

5. No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis;Radiotherapy and Oncology;2023-07